Document:

Exhibit
10.19

 

NON-DISCLOSURE, INTELLECTUAL
PROPERTY PROTECTION 

AND NON-SOLICITATION AGREEMENT

 

This Agreement
(“Agreement”) between Suneva Medical, Inc., a Delaware corporation, and its direct and indirect
affiliates and subsidiaries (hereinafter collectively referred to as the “Company”) and the undersigned employee
(“Employee”) is entered into and shall be effective as of the Employee’s employment date (the “Effective
Date”).

 

WHEREAS, Employee wishes to be employed by the Company; and

 

WHEREAS, Company
wishes to employ Employee subject to all of the terms and conditions hereinafter set forth, and Employee is willing to accept employment
by the Company on such terms and conditions;

 

NOW, THEREFORE,
in consideration of Employee’s employment by the Company, and other good and valuable consideration, the sufficiency of which consideration
is hereby acknowledged, and intending to be legally bound hereby, the Company and Employee agree as follows:

 

	1.	Definitions of Protectible Information.

 

a. “Intellectual
Property” means all rights, title, and interests of every kind and nature whatsoever, whether now known, or are in the progress
work efforts and have been documented in and to any intellectual property, including without limitation any ideas, inventions (whether
or not patentable), designs, improvements, discoveries, innovations, patents, trademarks, service marks, trade dress, trade names, trade
secrets, works of authorship, copyrights, films, audio and video tapes, other audio and visual works of any kind, scripts, sketches, models,
formulas, tests, analyses, software, firmware, computer processes, computer and other applications, creations, properties, and any documentation
or other memorialization containing or relating to the foregoing, in each case discovered, invented, created, written, developed, taped,
filmed, furnished, produced, or disclosed by or to Employee in the course of rendering services to the Company shall, as between the parties
hereto, to the maximum extent permitted by Section 2870 of the California Labor Code, a copy of which is attached hereto as Exhibit
A (“Section 2870”), be and remain the sole and exclusive property of the Company for any and all purposes and uses
whatsoever, and Employee and Employee’s successors and assigns shall have no right, title or interest of any kind or nature therein
or thereto, or in or to any results and proceeds therefrom. The Company shall have all rights, title and interest in such Intellectual
Property, to the maximum extent permitted by Section 2870, whether such Intellectual Property is conceived by Employee alone or with others
and whether conceived during regular working hours or other hours during the term of Employee’s employment and/or consultancy with
the Company and/or Artes Medical, Inc.

 

    

    

    

 

b. “Confidential
Information” means any and all information of any sort (whether merely remembered or embodied in a tangible or intangible
form) that is (i) directly or indirectly related to the Company’s or its subsidiaries’ or affiliates’ (including their
predecessors) current research, development or business and (ii) not generally or publicly known. Confidential Information includes, without
limitation, any and all oral, written, graphic, electronic, or machine readable information, observations and data obtained by Employee
while employed by the Company and its subsidiaries (or any of their predecessors) concerning the business or affairs of the Company or
any of its subsidiaries or affiliates, including information concerning acquisition opportunities in or reasonably related to the Company’s
or its subsidiaries’ or affiliates’ business or industry, the identities of the current, former employees, officers, directors,
advisers, attorneys, representatives, stockholders, suppliers and customers of the Company and its subsidiaries, development, transition
and transformation plans, methodologies and methods of doing business, strategic, marketing and expansion plans and strategies, financial
and business plans, financial data, pricing information, employee and consultant lists and telephone numbers, locations of sales representatives
and distributors, new and existing customer or supplier programs and services, customer terms, customer service and integration processes,
requirements and costs of providing service, support and equipment, technology, trade secrets, know-how, research, product plans, products,
developments, inventions, processes, designs, drawings, engineering, formulae, markets and potential markets, regulatory and quality assurance
information, medical reports, clinical data and analysis, biological materials that are being processed or used by the company, chemical
formulas and agreements with third parties.

 

	2.	Employee and Company Acknowledgements.

 

a. The
Employee acknowledges that: (a) as a part of Employee’s employment, Employee shall be afforded access to Confidential Information
and Intellectual Property (as defined herein); (b) public disclosure or utilization of such Confidential Information or Intellectual Property
could have an adverse effect on the Company and its business; and (c) the non-disclosure provisions of this Agreement are reasonable and
necessary to prevent the improper use or disclosure of Confidential Information or Intellectual Property.

 

b. The
Employee acknowledges that: (a) the Company’s business is national in scope and its products are marketed throughout the United
States; (b) the Company provides resources and training to Employee on its products and processes that is available only to employees
and cannot be acquired outside of the Company; and (c) the non-solicitation provisions of this Agreement are reasonable and necessary
to protect the Company’s goodwill with its customer base, its investment in its employees and its interests in its trade secrets,
Intellectual Property and Confidential Information.

 

c. The Company
recognizes the previous experience of Employee. To avoid any confusion, Employee may prior to executing this Agreement attach, as Exhibit
B hereto, a list of existing inventions to which Employee claims ownership as of the date of this Agreement and that Employee
desires to specifically clarify are not Intellectual Property subject to this Agreement.

 

    Page 2

    

    

 

	3.	Obligations Regarding Intellectual Property.

 

a. Employee
hereby acknowledges and agrees that all copyrightable works included in the definition of Intellectual Property shall be “works
made for hire” within the meaning of the Copyright Act of 1976, as amended (17 U.S.C. §101) (the “Act”),
and that Company is to be the “author” within the meaning of the Act. Employee acknowledges and agrees that all Intellectual
Property is the sole and exclusive property of the Company. In the event that title to any or all of the Company’s Intellectual
Property does not or may not, by operation of law, vest in Company, Employee hereby assigns to Company, all of Employee’s rights,
title and interests in all Intellectual Property and all copies relating to such Intellectual Property, in whatever medium fixed or embodied,
and in all writings relating thereto in Employee’s possession or control. Employee hereby expressly waives hereby any rights in
any Intellectual Property or any such work made for hire.

 

b. Employee
agrees not to file any patent, copyright or trademark applications relating directly or indirectly and will compete or block any Intellectual
Property. Employee agrees to assist Company whether before or after the termination of employment, in perfecting, registering, maintaining,
and enforcing, in any jurisdiction, Company’s rights in its Intellectual Property by performing promptly all acts and executing
all documents deemed necessary or convenient by Company at reasonable times and places and at the Company’s expense and will be
at an hourly rate equal or greater of the Employees base salary at date of termination

 

c. If
Company is unable, after duly reasonable effort, to secure Employee’s signature on any such documents, Employee hereby irrevocably
designates and appoints Company and its duly authorized officers and agents as Employee’s agent and attorney- in-fact, to do all
lawfully permitted acts (including but not limited to the execution, verification and filing of applicable documents) with the same legal
force and effect as if performed by Employee.

 

	4.	Obligations Regarding Confidential Information.

 

a. During his
employment with the Company and for a period of seven (7) years thereafter, Employee agrees that Employee will not: (a) use or
permit the use of any Confidential Information, however acquired, except as necessary within the scope of employment with the
Company to perform Employee’s duties; (b) duplicate or replicate or cause or permit others to duplicate or replicate any
document or other material in any medium embodying any Confidential Information, except as necessary in connection with
Employee’s employment with the Company; or (c) disclose or permit the disclosure of any Confidential Information to any person
outside the Company, without the prior written consent of the President of the Company, unless and to the extent that (i) the
Confidential Information becomes generally known to and available for use by the public other than as a result of Employee’s
acts or omissions or (ii) the Employee is ordered by a court of competent jurisdiction to disclose Confidential Information,
provided that Employee must (x) provide prompt written notice to the Company of any relevant process or pleadings that could lead to
such an order and (y) cooperate with the Company to contest, object to or limit such a request and, in any case, when revealing,
such Confidential Information to such court order.

 

    Page 3

    

    

 

b. Employee
acknowledges that Company owns all rights, title and interest in and to the Confidential Information. Employee acquires hereunder no rights,
title or interest in any Confidential Information.

 

c. Employee
agrees that Employee shall not remove from the Employer’s premises (except to the extent such removal is for purposes of the performance
of the Employee’s duties at home or while traveling, or except as otherwise specifically authorized by the Company), any Confidential
Information or Company property (e.g., computers, cell phones, memoranda, office supplies, software, etc). Upon termination of the Employee’s
employment, by either party, or upon the request of the Company during the Employee’s employment, Employee shall return to the Company
all of the Confidential Information and Company property in the Employee’s possession or subject to the Employee’s control,
and the Employee shall not retain any copies of such items. Upon request, Employee will confirm Employee has complied with all of the
terms of this provision.

 

	5.	No Outstanding Obligations. Employee herby represents
and warrants that: (a) Employee’s performance of the terms of this Agreement and as an employee of Company will not breach any
confidentiality or other agreement that Employee entered into with former employers or other entities, and (b) Employee is not bound
by any agreement, either oral or written, that conflicts with this Agreement.

 

	6.	Non-Solicitation. Employee agrees that, during his employment
with the Company and for a period of one (1) year following the termination of Employee’s employment with the Company (the “Post-Employment
Restricted Period”), Employee shall not, directly or indirectly, in any manner (whether on his own account, as an owner, operator,
officer, director, partner, manager, employee, agent, contractor, consultant or otherwise): in any way interfere with the relationship
between the Company or any of its subsidiaries and any customer, supplier, licensee or other business relation (or any customer, supplier,
licensee or other business relationship) of the Company or any of its subsidiaries (including, by making any negative or disparaging
statements or communications regarding the Company, any of its subsidiaries or any of their operations, officers, directors or investors
or can be reasonable expected to cause adverse impact to the Company). During the Post-Employment Restricted Period, Employee shall not,
directly or indirectly, in any manner (whether for his own account, as an owner, operator, officer, director, partner, manager, employee,
agent, contractor, consultant or otherwise): (i) hire or engage, or recruit, solicit or otherwise attempt to employ or retain or enter
into any business relationship with, any current consultant to the Company or any of its subsidiaries, (ii) induce or attempt to induce
any current or former employee of, or consultant to, the Company or any of its subsidiaries, to leave the employ of the Company or any
such subsidiary, or in any way interfere with the relationship between the Company or any of its subsidiaries and any their employees
or consultants, (iii) employ or retain or enter into any business relationship with any person who is an employee of or consultant to
the Company or any of its subsidiaries, or (iv) recommend the hiring of, or provide a reference for any person who was an employee of
or consultant to the Company or any of its subsidiaries.

 

    Page 4

    

    

 

	7.	Other Obligations. Employee acknowledges that the Company
from time to time may have agreements with other persons or entities which impose obligations or restrictions on the Company regarding
the confidential nature of such work. Employee agrees to be bound by all such obligations and restrictions regarding nondisclosure, confidentiality
or ownership which are made known to Employee and to take all action necessary on Employee’s part to discharge such obligations of the
Company thereunder.

 

	8.	Non-Disparagement. Employee and Company hereby agrees
that neither party will not directly or indirectly disparage the Company or disseminate, or cause or permit others to disseminate negative
statements regarding Company or any other employee, officer, director or agent of Company. Notwithstanding the foregoing, Neither party
is not hereby barred or restricted from exercising any right of speech or expression protected by applicable federal, state or local
law from restriction by Company. Further, in the event that the Company receives any inquiries regarding Employee, the Company agrees
to follow its policy of providing only a neutral reference setting forth dates of employment and positions held and to inform the inquiring
party that Company policy dictates that only such information be provided.

 

	9.	Employment Relationship. Nothing in this Agreement shall
be construed to alter the Employee’s status as an at-will employee.

 

	10.	Entire Agreement. This Agreement constitutes the entire
understanding of the parties with respect to the subject matter hereof and supersedes any understanding between the parties with respect
thereto. No provision of this Agreement may be changed or modified, nor may this Agreement be discharged in part or in whole, except
in writing, executed by the Employee the Company.

 

	11.	Remedies. Employee acknowledges and agrees that Company
would be irreparably injured by Employee’s material breach of this Agreement and that monetary remedies would be inadequate to
protect against any actual or threatened breach of this Agreement. Without prejudice to any other rights and remedies otherwise available
to Company, Employee agrees to the granting of equitable relief, including injunctive relief and specific performance, in favor of Company
with reasonable proof of actual damages to remedy or prevent any such breach. Further, Employee understands and agrees that Employee’s
material breach of this Agreement provides the Company with the right to recover its costs and fees, including attorneys’ fees,
incurred as a result of Employee’s breach of this Agreement.

 

    Page 5

    

    

 

	12.	Governing Law. This Agreement shall be governed by and
construed under the laws of the State of California, without regard to the choice of law provisions thereof.

 

	13.	Post-Employment Obligations. The obligations contained
in Sections 3-4 and 6-8 of this Agreement shall survive and continue in full force and effect regardless of the termination or expiration
of the employment, and shall be fully enforceable thereafter (subject to any termination provisions expressly provided for herein).

 

	14.	Assignment. The Company shall have the right to assign
its rights and obligations under this Agreement under the course of normal business operations or a business transaction involving a
transfer of Company assets or Intellectual property. This Agreement is personal to Employee, and Employee may not assign his/her rights
and obligations under this Agreement to any third-party.

 

	15.	Severability. The invalidity or unenforceability of any
provision herein shall not affect the validity or enforceability of any other provision herein. If a court of competent jurisdiction
determines that any portion of this Agreement is in violation of any statute or public policy, only the portions of this Agreement that
violate such statute or public policy shall be stricken, and all other portions of this Agreement that do not violate any statute or
public policy shall continue in full force and effect. Further, if any one or more of the provisions contained in this Agreement is determined
by a court of competent jurisdiction to be excessively broad as to duration, scope, activity or subject, or is unreasonable or unenforceable
under applicable laws, such provisions will be construed by limiting, reducing, modifying or amending them so as to be enforceable to
the maximum extent permitted by law. If the Agreement is held unenforceable in any jurisdiction, such holding will not impair the enforceability
of the Agreement in any other jurisdiction.

 

[Signature Page to Follow]

 

    Page 6

    

    

 

IN WITNESS WHEREOF,
Company has caused this Agreement to be executed by its duly authorized officer, and the Employee has signed this Agreement, as of the
Effective Date.

 

	 	 	 
	Signature of Employee	 	Signature of Company Representative
	 	 	 
	 	 	 
	Print Name	 	Print Name
	 	 	 
	 	 	 
	Date	 	Date

 

    Page 7

    

    

 

Exhibit A

 

Section 2870 of the California Labor Code

 

		(a)	Any provision in an employment agreement which provides that
an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention
that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret
information except for those inventions that either:

 

		1.	Relate at the time of conception or reduction to practice
of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or

     

		2.	Result from any work performed by the employee for the employer.

 

		(b)	To the extent a provision in an employment agreement purports
to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision
is against the public policy of this state and is unenforceable.

 

    Page 8

    

    

 

Exhibit B

 

Employee Inventions

 

 

 

Page 9Exhibit 10.20

 

SUNEVA MEDICAL, INC.

 

EMPLOYMENT AGREEMENT

 

THE EMPLOYMENT AGREEMENT (the
“Agreement”) is made as of February ___, 2019 (the “Effective Date”), between Suneva Medical, Inc.,
a Delaware corporation (the “Company”), and Brian Pilcher (the “Employee”). The Company and Employee
are sometimes hereinafter referred to individually as a “Party” and together as “Parties.”

 

WHEREAS, the Company desires
to retain Employee to serve as the Chief Science Officer of the Company on the terms set forth herein;

 

WHEREAS, Employee acknowledges
that in connection with his employment, Employee will have access to valuable Confidential Information (as defined below) including, but
not limited to, methods of doing business, business plans and trade secrets;

 

NOW THEREFORE, in consideration
of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the Parties hereto agree as follows:

 

1. Employment;
Term. Employee’s first day of employment with the Company under the Agreement (the “Start Date”) will be
March 4, 2019. The Company will employ Employee, and Employee hereby accepts employment with the Company, upon the terms and conditions
set forth in the Agreement until terminated in accordance with Section 5 (the “Employment Period”).

 

2. Position
and Duties

 

(a) During
the Employment Period, Employee will serve as the Chief Science Officer of the Company and will have the normal duties, responsibilities
and authority of the office, subject to the power of the Chief Executive Officer and/or board of directors of the Company (the “Board”)
to expand or limit such duties, responsibilities and authority.

 

(b) During
the Employment Period, Employee will report to the Chief Operating Officer or as assigned by Chief Executive Officer and will devote his
best efforts and full business time and attention to the business and affairs of the Company and any Subsidiaries and to the performance
of such duties as may be assigned from time to time by the Company. Employee will act in the best interest of the Company and, except
as may be specifically permitted by the Board in writing, will not engage in any other business activity. Employee will perform his duties,
responsibilities and functions on behalf of the Company hereunder to the best of his abilities in a diligent, trustworthy, businesslike
and efficient manner.

 

(c) Employee
will be field based and will be required to travel frequently connection with Company business.

 

     

     

    

 

3. Compensation.

 

(a) Employee’s
base salary will be Three Hundred Thousand dollars ($300,000) on an annualized basis (which salary may be adjusted by the Company from
time to time, the “Base Salary”). Employee’s Base Salary will be paid by the Company in regular installments
in accordance with the Company’s general payroll practices.

 

(b) In
addition to the Base Salary, for each complete calendar year during the Employment Period so long as Employee is employed on the date
such bonus is paid, Employee will be eligible to receive a discretionary bonus (“Bonus”) of up to 40% of Base Salary
based on several performance-related targets to be determined by the Chief Executive Officer and/or Board under the Company’s performance
based incentive bonus plan. Whether to award any Bonus amount and the amount of such Bonus will be determined by the Company’s Board
of Directors and/or the CEO in the exercise of their reasonable discretion with reference to the applicable incentive bonus plan. Any
bonus for 2019 will be prorated based on a 365-day fiscal year.

 

(c) Employee will be granted
300,000 stock options under the Company’s stock option plan (the “Option Plan”) subject to the terms and conditions
therein and Board approval procedures under the Option Plan as follows: time-based stock options for shares of the Company’s common stock,
par value $0.001 per share (the “Common Stock”) (the “Time-based Options”). The Time-based Options
shall vest in accordance with the applicable stock option plan (the “Plan”), the applicable stock option agreement(s)
and the applicable option grant(s), in each case subject to Employee’s continued service with the Company, provided that if Employee’s
employment with the Company is terminated either by the Company without Cause (defined below) or by Employee for Good Reason (defined
below) at any time on or after the date that is thirty (30) days prior to or within twelve (12) months following an Equity Event (defined
below), then the vesting applicable to any equity grants then held by Employee shall be accelerated in full immediately prior to the
closing of the Equity Event. The per share exercise price of the stock options granted to Employee will be equal to fair market value
of the Company’s common stock on the Grant Date as determined in good faith by the Board.

 

(d) Employee
may be entitled to receive subsequent stock option grants with terms commensurate with Employee’s position as Chief Science Officer
in the aesthetics industry to the extent approved by the Board in its sole discretion.

 

(e) All
amounts payable to Employee hereunder will be subject to all required withholding by the Company.

 

4. Benefits.
In addition to the Base Salary and other compensation provided for in Section 3 above, Employee will be entitled to the following
benefits during the Employment Period:

 

(a) Employee
will be entitled to participate in the Company’s health and welfare benefit programs for which other executive employees of the
Company are generally eligible, subject to any eligibility requirements of such plans and programs. Employee will not accrue paid vacation
or paid time off. Employee will be eligible for paid sick leave to the extent required by applicable law.

 

    - 2 -

     

    

 

(b) The
Company will reimburse Employee for all reasonable expenses incurred in the course of performing his duties and responsibilities under
the Agreement which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment
and other business expenses, subject to the Company’s requirements with respect to timely reporting and documentation of such expenses.
Any reimbursement payments that are taxable income to Employee will be paid to Employee promptly after submission, but in no event later
than the December 31st of the calendar year following the year in which the expenses were incurred.

 

5. Termination

 

(a) Employee’s
employment with the Company and the Employment Period will end on the earlier of (i) Employee’s death or Disability (defined below),
(ii) Employee’s resignation or (iii) termination by the Company at any time with or without Cause. Except as otherwise
provided herein, any termination of the Employment Period by the Company or by Employee will be effective as specified in a written notice
from the terminating Party to the other Party.

 

(b) If
the Employment Period is terminated (i) pursuant to Section 5(a)(i) above or (ii) by the Company with Cause, or if Employee resigns
(other than for Good Reason), then Employee will only be entitled to receive his Base Salary through the date of such termination
and will not thereafter be entitled to any other salary, bonus, severance, compensation or benefits from the Company or any of its Subsidiaries
or affiliates or their benefit plans, other than vested retirement benefits or insurance continuation rights expressly required under
applicable law (such as the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”). In the event
of a termination under the Section 5(b), Employee’s unvested stock options shall be forfeited and immediately cease to be
exercisable effective as of the date of such termination. Vested stock options shall remain exercisable by Employee until the earlier
of (x) the three (3) month anniversary of such termination and (y) any expiration date of such options, as more fully provided for in
the Option Plan.

 

(c) If
(i)  Employee’s employment with the Company is terminated either by the Company without Cause or by Employee with Good Reason
and (ii) Employee executes and delivers a general release (the “Release”) in favor of the Company and its affiliates
in form and substance satisfactory to the Company and such Release is not revoked or rescinded so that it becomes effective in accordance
with its terms no later than sixty (60) days following the date of Employee’s termination, and so long as Employee continues to
comply with the terms of the Agreement and the Release, Employee will be entitled to receive continuation of his Base Salary and group
health plan benefits to the extent authorized by and consistent with COBRA subject to payment of premiums by the Company, for a period
equal to six (6) months after the date of termination (the “Severance Period”) (provided that any amounts otherwise
payable prior to the effective date of the Release shall instead accrue and be paid during the first payroll period that follows the Release
effective date, with the remainder of the payments made as originally scheduled). Notwithstanding the foregoing, the Company’s obligations
to pay Employee’s COBRA premiums shall cease during the Severance Period to the extent that Employee becomes eligible to participate
in another entity’s health and disability insurance programs. Employee agrees to promptly advise the Company of the amount and source
of any compensation received or earned by him for services rendered and/or any eligibility to participate in another entity’s health
and disability insurance plan during the Severance Period. Additionally, if the Company determines, in its sole discretion, that the Company
cannot provide the COBRA premium benefits to Employee without potentially incurring financial costs or penalties under applicable law
(including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof pay Employee a taxable
cash amount, which payment shall be made regardless of whether the Employee or his qualifying family members elect COBRA continuation
coverage (the “Health Care Benefit Payment”). The Health Care Benefit Payment shall be paid in monthly or bi-weekly
installments on the same schedule that the COBRA premiums would otherwise have been paid to the insurer. The Health Care Benefit Payment
shall be equal to the amount that the Company otherwise would have paid for COBRA insurance premiums (which amount shall be calculated
based on the premium for the first month of coverage), and shall be paid until the expiration of the Severance Period.

 

    - 3 -

     

    

 

(d) The
severance payments payable to Employee pursuant to Section 5(c) will be paid at the time and in the manner set forth in Section
3 hereof. Notwithstanding anything to the contrary herein, the following provisions apply to the extent severance benefits provided
herein are subject to Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations
and other guidance thereunder and any state law of similar effect (collectively “Section 409A”). Severance benefits
shall not commence until Employee has a “separation from service” for purposes of Section 409A. Each installment of severance
benefits is a separate “payment” for purposes of Treas. Reg. Section 1.409A-2(b)(2)(i), and the severance benefits are intended
to satisfy the exemptions from application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(5)
and 1.409A-1(b)(9). However, if such exemptions are not available and Employee is, upon separation from service, a “specified employee”
for purposes of Section 409A, then, solely to the extent necessary to avoid adverse personal tax consequences under Section 409A, the
timing of the severance benefits payments shall be delayed until the earlier of (i) six (6) months and one day after Employee’s
separation from service, or (ii) Employee’s death. If the severance benefits are not covered by one or more exemptions from the
application of Section 409A and the Release could become effective in the calendar year following the calendar year in which Employee
separates from service, Release will not be deemed effective any earlier than the sixtieth (60th) day following the Employee’s
separation from service. None of the severance benefits will be paid or otherwise delivered prior to the effective date (or deemed effective
date) of the Release. Except to the minimum extent that payments must be delayed because Employee is a “specified employee”
or until the effectiveness of the Release, all amounts will be paid as soon as practicable in accordance with the Company’s normal
payroll practices. The severance benefits are intended to qualify for an exemption from application of Section 409A or comply with its
requirements to the extent necessary to avoid adverse personal tax consequences under Section 409A, and any ambiguities herein shall be
interpreted accordingly.

 

(e) Except
as otherwise expressly provided herein, all of Employee’s rights to salary, bonuses, fringe benefits, severance and other compensation
hereunder or under any policy or program or benefit plans of the Company or any of its Subsidiaries which might otherwise accrue or become
payable on or after the termination of the Employment Period will cease upon such termination other than vested retirement benefits or
insurance continuation rights expressly required under applicable law (such as COBRA).

 

(f) For
purposes of the Agreement, the following terms shall have the following definitions:

 

(i) “Cause”
will mean (A) the commission of a felony or other crime involving moral turpitude or the commission of any other act or omission involving
misappropriation, dishonesty, unethical business conduct, disloyalty, fraud or breach of fiduciary duty, (B) reporting to work under the
influence of alcohol, (C) the use of illegal drugs (whether or not at the workplace) or other conduct, even if not in conjunction with
his duties hereunder, which could reasonably be expected to, or which does, cause the Company public disgrace or disrepute or economic
harm, (D) failure to perform duties as lawfully directed by the Chief Executive Officer, the Board or any other officer or representative
of the Company to whom Employee reports, (E) gross negligence or willful misconduct with respect to the Company or any of its affiliates
or in the performance of Employee’s duties hereunder, (F) obtaining any personal profit not thoroughly disclosed to and approved
by the Board in connection with any transaction entered into by, or on behalf of, or in relation to, the Company, (G) violating any of
the terms of the Company’s established rules or policies which, if curable, is not cured to the Board’s reasonable satisfaction
within fifteen (15) days after written notice thereof to Employee, (H) the unwillingness to meet the performance objectives outlined by
the Board, or (I) any other material breach of the Agreement or any other agreement between Employee and the Company which, if curable,
is not cured to the Board’s reasonable satisfaction within fifteen (30) days after written notice thereof to Employee.

 

    - 4 -

     

    

 

(ii) “Disability”
shall mean Employee has become permanently disabled within the meaning of any policy of disability income insurance covering employees
of the Company then in force. In the event the Company has no policy of disability income insurance covering employees of the Company
in force when Employee becomes disabled, the term “Disability” shall mean the inability of Employee to perform Employee’s
duties under the Agreement, whether with or without reasonable accommodation, by reason of any incapacity, physical or mental, which the
Board, based upon medical advice or an opinion provided by a licensed physician acceptable to the Board, determines to have incapacitated
Employee from satisfactorily performing all of Employee’s usual services for the Company, with or without reasonable accommodation,
for a period of at least one hundred twenty (120) days during any twelve (12) month period (whether or not consecutive). Based upon such
medical advice or opinion, the determination of the Board shall be final and binding and the date such determination is made shall be
the date of such Disability for purposes of the Agreement.

 

(ii) “Equity
Event” will mean either: (A) a transaction or series of related transactions in which a person, or a group of related persons,
acquires from stockholders of the Company shares representing more than fifty percent (50%) of the outstanding voting power of the Company,
except for transactions which the Board determines in good faith are primarily financing transactions, (B) a merger or consolidation in
which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital
stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company in which the shares of capital
stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged
for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power,
of the capital stock of (1) the surviving or resulting corporation or (2) if the surviving or resulting corporation is a wholly owned
subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting
corporation, excluding in any case transactions which the Board determines in good faith are primarily financing transactions, or (C)
the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company
or any of its Subsidiaries of all or substantially all the assets of the Company and its Subsidiaries taken as a whole, except where such
sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.

 

    - 5 -

     

    

 

(iii) “Good
Reason” will mean the occurrence of any of the following without Employee’s consent: (A) Employee is involuntarily assigned
a position materially inconsistent with Employee’s position, (B) a relocation of Employee’s principal place of employment
by more than 100 miles, or (C) the Company commits any material breach of the Agreement, provided that any such occurrence (x)
shall only constitute “Good Reason” during the thirty (30) day period following the date such event occurs (after which it
shall be deemed waived by Employee if prior thereto Employee has not exercised his right to resign for “Good Reason”) and
(y) shall only constitute “Good Reason” if Employee gives written notice to the Company of his intent to terminate the
Agreement and the Company fails to remedy the same within thirty (30) days after such.

 

6. Section
280G

 

(a) If
any payment or benefit Employee would receive from the Company or otherwise (“Payment”) would (i) constitute
a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for the sentence, be subject to the excise
tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be equal to the Reduced
Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the
Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after
taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest
applicable marginal rate), results in Employee’s receipt, on an after-tax basis, of the greater economic benefit notwithstanding
that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding
sentence and the Reduced Amount is determined pursuant to clause (x) of the preceding sentence, the reduction shall occur in the manner
(the “Reduction Method”) that results in the greatest economic benefit for Employee. If more than one method
of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata (the “Pro Rata Reduction
Method”). Notwithstanding the foregoing, if the Reduction Method or the Pro Rata Reduction Method would result in any portion
of the Payment being subject to taxes pursuant to Section 409A of the Code that would not otherwise be subject to taxes pursuant to Section
409A of the Code, then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as to avoid
the imposition of taxes pursuant to Section 409A of the Code as follows: (A) as a first priority, the modification shall preserve to the
greatest extent possible, the greatest economic benefit for Employee as determined on an after-tax basis; (B) as a second priority, Payments
that are contingent on future events (e.g., being terminated without cause), shall be reduced (or eliminated) before Payments that are
not contingent on future events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning
of Section 409A of the Code shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of
Section 409A of the Code.

 

    - 6 -

     

    

 

(b) In
the event it is subsequently determined by the Internal Revenue Service that some portion of the Reduced Amount as determined pursuant
to clause (x) in the preceding paragraph is subject to the Excise Tax, Employee agrees to promptly return to the Company a sufficient
amount of the Payment so that no portion of the Reduced Amount is subject to the Excise Tax. For the avoidance of doubt, if the Reduced
Amount is determined pursuant to clause (y) in the preceding paragraph, Employee will have no obligation to return any portion of the
Payment pursuant to the preceding sentence.

 

(c) Unless
Employee and the Company agree on an alternative accounting firm, the accounting firm engaged by the Company for general tax compliance
purposes as of the day prior to the effective date of the change in control shall perform the foregoing calculations. If the accounting
firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the change in control,
the Company shall appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company shall bear
all expenses with respect to the determinations by such accounting firm required to be made hereunder.

 

(d) The
Company shall use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder to provide
its calculations, together with detailed supporting documentation, to Employee and the Company within fifteen (15) calendar days after
the date on which Employee’s right to a Payment is triggered (if requested at that time by Employee or the Company) or such other
time as requested by Employee or the Company.

 

7. Confidential
Information

 

(a) Employee
recognizes and acknowledges that the continued success of the Company and its Subsidiaries depends upon the use and protection of a large
body of confidential and proprietary information and that Employee will have access to certain Confidential Information of the Company,
its affiliates and Persons with which the Company and its affiliates do business, and that such Confidential Information constitutes valuable,
special and unique property of the Company, its affiliates and such other Persons. “Confidential Information” includes
all information of any sort (whether merely remembered or embodied in a tangible or intangible form) that is (i) related to the Company’s
or its affiliates’ (including their predecessors) current or potential business and (ii) not generally or publicly known. Confidential
Information includes, without limitation, any and all oral, written, graphic, electronic or machine readable information, observations
and data obtained by Employee while employed by the Company (or any of its predecessors) concerning the business or affairs of the Company
or any of its affiliates, including information concerning acquisition opportunities in or reasonably related to the Company’s or
its affiliates’ business or industry, the identities of the current, former or prospective employees, officers, directors, advisers,
attorneys, representatives, stockholders, suppliers and customers of the Company, development, transition and transformation plans, methodologies
and methods of doing business, strategic, marketing and expansion plans and strategies, financial and business plans, financial data,
pricing information, employee and consultant lists and telephone numbers, locations of sales representatives and distributors, new and
existing customer or supplier programs and services, customer terms, customer service and integration processes, requirements and costs
of providing service, support and equipment, technology, trade secrets, know-how, research, product plans, products, developments, inventions,
processes, designs, drawings, engineering, formulae, markets and potential markets, regulatory and quality assurance information, medical
reports, clinical data and analysis, biological materials, chemical formulas and agreements with third parties. Employee agrees that he
will use the Confidential Information only as necessary and only in connection with the performance of his duties hereunder. Employee
agrees that they will not disclose to any unauthorized Person or use for any other purposes (except as described in the immediately preceding
sentence) any Confidential Information without the prior written consent of the Board, unless and to the extent that (a) the Confidential
Information becomes generally known to and available for use by the public other than as a result of Employee’s acts or omissions
or (b) Employee is ordered by a court of competent jurisdiction to disclose Confidential Information, provided that Employee must (i)
provide prompt written notice to the Company of any relevant process or pleadings that could lead to such an order and (ii) cooperate
with the Company to contest, object to or limit such a request and, in any case, when revealing, such Confidential Information to such
court order.

 

    - 7 -

     

    

 

(b) Employee
understands that the Company and its affiliates may receive from third parties confidential or proprietary information (“Third
Party Information”) subject to a duty on the Company and its affiliates to maintain the confidentiality of such information
and to use it only for certain limited purposes. During the Employment Period and thereafter, and without in any way limiting the foregoing
provisions of the Section 7, Employee will hold Third Party Information in the strictest confidence and will not disclose
to anyone (other than personnel and consultants of the Company or its affiliates who need to, and are authorized to, know such information
in connection with their work for the Company or its Subsidiaries and affiliates) or use Third Party Information unless expressly authorized
by the Board.

 

(c) During
the Employment Period, Employee will not improperly use or disclose any confidential information or trade secrets, if any, of any former
employers or any other Person, and will not bring onto the premises of the Company or any of its Subsidiaries or affiliates any documents
or any property belonging to any former employer or any other Person unless consented to in writing by the Board.

 

8. Return
of Corporate Property. Employee acknowledges and agrees that all notes, records, reports, sketches, plans, unpublished memoranda or
other documents, whether in paper, electronic or other form (and all copies thereof), held by Employee concerning any information relating
to the business of the Company, whether confidential or not, are the property of the Company. Employee will deliver to the Company at
the termination or expiration of the Employment Period, or at any other time the Company may request, all property of the Company or its
affiliates, including, without limitation, all equipment, files, property, memoranda, notes, plans, records, reports, computer tapes,
printouts and software, Confidential Information and other documents and data (and all electronic, paper or other copies thereof) in the
possession or control of Employee. Employee will take any and all actions reasonably deemed necessary or appropriate by the Company from
time to time in its sole discretion to ensure the continued confidentiality and protection of the Confidential Information. Employee will
notify the Company promptly and in writing of any circumstances of which Employee has knowledge relating to any disclosure to or possession
or use of any Confidential Information other than as specifically authorized herein.

 

    - 8 -

     

    

 

9. Non-Solicitation

 

(a) So
long as Employee is employed by the Company and for one year thereafter (the “Nonsolicit Period”), Employee will not,
either directly or through others, solicit or attempt to solicit any employee, independent contractor or consultant of the company to
terminate his or his relationship with the Company in order to become an employee, consultant or independent contractor to or for any
other person or entity.

 

(b) Employee
acknowledges and agrees that the restrictions contained in the Section 9 with respect to time and scope of activity are reasonable
and do not impose a greater restraint than is necessary to protect the trade secrets and other legitimate business interests of the Company
and that Employee has had the opportunity to review the provisions of the Agreement with Employee’s legal counsel. In particular,
Employee agrees and acknowledges that the Company expends significant time and effort developing and protecting the confidentiality of
their methods of doing business, technology, customer lists, long term customer relationships and trade secrets and such methods, technology,
customer lists, customer relationships and trade secrets have significant value. However, if, at the time of enforcement of the Section
9, a court holds that the duration or scope of activity restrictions stated herein are unreasonable under circumstances then existing
or impose a greater restraint than is necessary to protect the trade secrets and other business interests of the Company, the Parties
agree that the maximum duration or scope under such circumstances will be substituted for the stated duration or scope and that the court
will be allowed to revise the restrictions contained herein to cover the maximum duration and scope permitted by law, in all cases giving
effect to the intent of the Parties that the restrictions contained herein be given effect to the broadest extent possible. The existence
of any claim or cause of action by Employee against the Company or any of its affiliates, whether predicated on the Agreement or otherwise,
will not constitute a defense to the enforcement by the Company of the provisions of Sections 7, 8 or the Section
9, which Sections will be enforceable notwithstanding the existence of any breach by the Company. Notwithstanding the foregoing, Employee
will not be prohibited from pursuing such claims or causes of action against the Company. Employee consents to the Company notifying any
future employer of Employee of Employee’s obligations under Sections 7, 8 and the Section 9 of the Agreement.

 

(c) In
the event of the breach or a threatened breach by Employee of any of the provisions of Sections 7, 8 or the Section 9,
the Company, in addition and supplementary to any other rights and remedies existing in their favor, will be entitled to specific performance
and/or injunctive or other equitable relief from a court of competent jurisdiction in order to enforce or prevent any violations of the
provisions hereof (without posting a bond or other security). In addition, in the event of an alleged breach or violation by Employee
of the Section 9, the Nonsolicit Period will be tolled until such breach or violation has been duly cured.

 

    - 9 -

     

    

 

(d) If
the Company (i) brings any action or proceeding to enforce any provision of the Agreement or to obtain damages as a result of a breach
of the Agreement or to enjoin any breach of the Agreement and (ii) prevails in such action or proceeding, then Employee will, in addition
to any other rights and remedies available to the Company, reimburse the Company for any and all reasonable costs and expenses (including
attorneys’ fees) incurred by the Company in connection with such action or proceeding.

 

10. Employee’s
Representations. Employee hereby represents and warrants to the Company that (i) he has entered into the Agreement of his own free
will for no consideration other than as referred to herein, (ii) the execution, delivery and performance of the Agreement by Employee
does not and will not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or
decree to which Employee is a party or by which Employee is bound and (iii) upon the execution and delivery of the Agreement by the
Company, the Agreement will be the valid and binding obligation of Employee, enforceable in accordance with its terms. Employee hereby
acknowledges and represents that Employee has had the opportunity to consult with independent legal counsel regarding Employee’s
rights and obligations under the Agreement and that Employee fully understands the terms and conditions contained herein.

 

11. Other
Definitions

 

“Person” means any natural person,
corporation, general partnership, limited partnership, limited liability company or partnership, proprietorship, other business organization,
trust, union, association or governmental or regulatory entities, department, agency or authority.

 

12. Survival.
Sections 5 through 25 will survive and continue in full force in accordance with their terms notwithstanding the termination
of the Employment Period or the Agreement.

 

13. Notices.
Any notice provided for in the Agreement will be in writing and will be either personally delivered, sent by reputable overnight courier
service, sent by facsimile (with hard copy to follow by regular mail) or mailed by first class mail, return receipt requested, to the
recipient at the address below indicated:

 

Notices to Employee:

Brian Pilcher

[_]

[__]

Email: [__]

 

Notices to the Company:

 

Suneva Medical, Inc.

5870 Pacific Center Blvd.

San Diego, CA 92121

Attn:Chief Executive Officer

Email: [__]

 

or such other address or to the attention of such
other Person as the recipient Party will have specified by prior written notice to the sending Party. Any notice under the Agreement will
be deemed to have been given when so delivered, sent or mailed.

 

    - 10 -

     

    

 

14. Severability.
Whenever possible, each provision of the Agreement will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of the Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule
in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any action in any other jurisdiction,
but the Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
had never been contained herein.

 

15. Complete
Agreement. The Agreement, along with any proprietary or confidential information and inventions assignment agreement required by the
Company, embodies the complete agreement and understanding among the Parties and supersedes and preempts any prior understandings, agreements
or representations by or among the Parties, written or oral, which may have related to the subject matter hereof in any way. Upon the
Effective Date, Employee hereby releases the Company and all of its subsidiaries and waives any claims or rights Employee may have under
any prior or existing agreement or understanding with the Company or any of its subsidiaries, affiliates or predecessors, including, but
not limited to, any claim for severance, any bonus or other benefits.

 

16. Counterparts.
The Agreement may be executed in separate counterparts (including by facsimile signature pages), each of which is deemed to be an original
and all of which taken together constitute one and the same agreement.

 

17. No
Strict Construction. The Parties hereto jointly participated in the negotiation and drafting of the Agreement. The language used in
the Agreement will be deemed to be the language chosen by the Parties hereto to express their collective mutual intent, the Agreement
will be construed as if drafted jointly by the Parties hereto, and no rule of strict construction will be applied against any Person.

 

18. Successors
and Assigns. The Agreement is intended to bind and inure to the benefit of and be enforceable by Employee, the Company and their respective
heirs, successors and assigns. Employee may not assign his rights or delegate his duties or obligations hereunder without the prior written
consent of the Company. The Company may assign its rights and obligations hereunder (including without limitation its rights under Section
9), without the consent of, or notice to, Employee, to any of the Company’s affiliates or to any Person that acquires the Company
or any portion of its business or its assets, in which case all references to the Company will refer to such assignee.

 

    - 11 -

     

    

 

19. Choice
of Law; Exclusive Venue. The agreement, and all issues and questions concerning the construction, validity, enforcement and interpretation
of the agreement, will be governed by, and construed in accordance with, the internal laws of the State of California, without giving
effect to any choice of law or conflict of law rules or provisions (whether of the State of California or any other jurisdiction) that
would cause the application of the laws of any jurisdiction other than the state of California. The parties agree that all disputes, legal
actions, suits and proceedings arising out of or relating to the agreement must be brought exclusively in a federal district court located
in the Southern District of California or a California State Court in San Diego County (collectively the “Designated Courts”).
Each party hereby consents and submits to the exclusive jurisdiction of the Designated Courts. No legal action, suit or proceeding with
respect to the agreement may be brought in any other forum. Each party hereby irrevocably waives all claims of immunity from jurisdiction
and any objection which such party may now or hereafter have to the laying of venue of any suit, action or proceeding in any Designated
Court, including any right to object on the basis that any dispute, action, suit or proceeding brought in the Designated Courts has been
brought in an improper or inconvenient forum or venue.

 

20. Business
Days. If any time period for giving notice or taking action hereunder expires on a day which is a Saturday, Sunday or legal holiday
in the state in which the Company’s chief-executive office is located, the time period shall automatically be extended to the business
day immediately following such Saturday, Sunday or legal holiday.

 

21. Withholding.
The Company and its Subsidiaries will be entitled to deduct or withhold from any amounts owing to Employee any federal, state, local or
foreign withholding taxes, excise tax, or employment taxes (“Taxes”) imposed with respect to Employee’s compensation
or other payments from the Company or any of its Subsidiaries or Employee’s ownership interest in the Company or any of its Subsidiaries
or its parent (including, without limitation, wages, bonuses, dividends, the receipt or exercise of equity options and/or the receipt
or vesting of restricted equity). In the event the Company or any of its Subsidiaries does not make such deductions or withholdings, Employee
will indemnify and hold harmless the Company and its Subsidiaries for any amounts paid with respect to any such Taxes.

 

22. Corporate
Opportunities. During the Employment Period, Employee will submit to the Board all business, commercial and investment opportunities
or offers presented to Employee or of which Employee becomes aware which relate to the businesses of the Company as such businesses of
the Company exist at any time during the Employment Period (“Corporate Opportunities”). During the Employment Period,
unless approved by the Board, Employee will not accept or pursue, directly or indirectly, any Corporate Opportunities on Employee’s
own behalf.

 

    - 12 -

     

    

 

23. Assistance
in Proceedings. During the Employment Period and thereafter, Employee will cooperate with the Company in any internal investigation
or administrative, regulatory or judicial proceeding as reasonably requested by the Company (including, without limitation, Employee being
available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company’s request to
give testimony without requiring service of a subpoena or other legal process, volunteering to the Company all pertinent information and
turning over to the Company all relevant documents which are or may come into Employee’s possession, all at times and on schedules
that are reasonably consistent with Employee’s other permitted activities and commitments). In the event the Company requires Employee’s
cooperation in accordance with the Section 23, the Company will pay Employee a reasonable per diem as determined by the Board
and reimburse Employee for reasonable expenses incurred in connection therewith (including lodging and meals, upon submission of receipts).

 

24. Waiver
of Statutory Limitations Periods. Employee agrees that any claim against the Company relating to the employment relationship between
the Company and Employee (including the termination of the employment relationship) must be brought against the Company within 180 days
of the event giving rise to the claim, or within the applicable statutory limitations period (whichever period is shorter), or else Employee’s
claim is forever barred. Employee waives any other limitations periods.

 

25. Amendment
and Waiver. The provisions of the Agreement may be amended or waived only with the prior written consent of the Company and Employee
in a formal instrument, and no course of conduct or course of dealing or failure or delay by any Party hereto in enforcing or exercising
any of the provisions of the Agreement will affect the validity, binding effect or enforceability of the Agreement or be deemed to be
an implied waiver of any provision of the Agreement.

 

* * * * *

    - 13 -

     

    

 

IN WITNESS WHEREOF, the Parties
hereto have executed the Employment Agreement as of the date first written above.

 

	 	SUNEVA MEDICAL, INC.
	 	 	 
	 	By:	 
	 	Printed Name:	 
	 	Title:	 
	 	 	 
	 	 
	 	Brian Pilcher	 

 

 

 

- 14 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]